Zobrazeno 1 - 10
of 992
pro vyhledávání: '"Sanchez PE"'
Autor:
Yulyaningsih E; Denali Therapeutics, South San Francisco, United States., Suh JH; Denali Therapeutics, South San Francisco, United States., Fanok M; Denali Therapeutics, South San Francisco, United States., Chau R; Denali Therapeutics, South San Francisco, United States., Solanoy H; Denali Therapeutics, South San Francisco, United States., Takahashi R; Denali Therapeutics, South San Francisco, United States., Bakardjiev AI; Denali Therapeutics, South San Francisco, United States., Becerra I; Denali Therapeutics, South San Francisco, United States., Benitez NB; Denali Therapeutics, South San Francisco, United States., Chiu CL; Denali Therapeutics, South San Francisco, United States., Davis SS; Denali Therapeutics, South San Francisco, United States., Dowdle WE; Denali Therapeutics, South San Francisco, United States., Earr T; Denali Therapeutics, South San Francisco, United States., Estrada AA; Denali Therapeutics, South San Francisco, United States., Gill A; Denali Therapeutics, South San Francisco, United States., Ha C; Denali Therapeutics, South San Francisco, United States., Haddick PCG; Denali Therapeutics, South San Francisco, United States., Henne KR; Denali Therapeutics, South San Francisco, United States., Larhammar M; Denali Therapeutics, South San Francisco, United States., Leung AW; Denali Therapeutics, South San Francisco, United States., Maciuca R; Denali Therapeutics, South San Francisco, United States., Memarzadeh B; Denali Therapeutics, South San Francisco, United States., Nguyen HN; Denali Therapeutics, South San Francisco, United States., Nugent AA; Denali Therapeutics, South San Francisco, United States., Osipov M; Denali Therapeutics, South San Francisco, United States., Ran Y; Denali Therapeutics, South San Francisco, United States., Rebadulla K; Denali Therapeutics, South San Francisco, United States., Roche E; Denali Therapeutics, South San Francisco, United States., Sandmann T; Denali Therapeutics, South San Francisco, United States., Wang J; Denali Therapeutics, South San Francisco, United States., Lewcock JW; Denali Therapeutics, South San Francisco, United States., Scearce-Levie K; Denali Therapeutics, South San Francisco, United States., Kane LA; Denali Therapeutics, South San Francisco, United States., Sanchez PE; Denali Therapeutics, South San Francisco, United States.
Publikováno v:
ELife [Elife] 2024 Sep 17; Vol. 12. Date of Electronic Publication: 2024 Sep 17.
Autor:
Barker SJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Thayer MB; Denali Therapeutics Inc., South San Francisco, CA, USA., Kim C; Denali Therapeutics Inc., South San Francisco, CA, USA., Tatarakis D; Denali Therapeutics Inc., South San Francisco, CA, USA., Simon MJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Dial R; Denali Therapeutics Inc., South San Francisco, CA, USA., Nilewski L; Denali Therapeutics Inc., South San Francisco, CA, USA., Wells RC; Denali Therapeutics Inc., South San Francisco, CA, USA., Zhou Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Afetian M; Ionis Pharmaceuticals, Carlsbad, CA, USA., Akkapeddi P; Denali Therapeutics Inc., South San Francisco, CA, USA., Chappell A; Ionis Pharmaceuticals, Carlsbad, CA, USA., Chew KS; Denali Therapeutics Inc., South San Francisco, CA, USA., Chow J; Denali Therapeutics Inc., South San Francisco, CA, USA., Clemens A; Denali Therapeutics Inc., South San Francisco, CA, USA., Discenza CB; Denali Therapeutics Inc., South San Francisco, CA, USA., Dugas JC; Denali Therapeutics Inc., South San Francisco, CA, USA., Dwyer C; Ionis Pharmaceuticals, Carlsbad, CA, USA., Earr T; Denali Therapeutics Inc., South San Francisco, CA, USA., Ha C; Denali Therapeutics Inc., South San Francisco, CA, USA., Ho YS; Denali Therapeutics Inc., South San Francisco, CA, USA., Huynh D; Denali Therapeutics Inc., South San Francisco, CA, USA., Lozano EI; Denali Therapeutics Inc., South San Francisco, CA, USA., Jayaraman S; Denali Therapeutics Inc., South San Francisco, CA, USA., Kwan W; Denali Therapeutics Inc., South San Francisco, CA, USA., Mahon C; Denali Therapeutics Inc., South San Francisco, CA, USA., Pizzo M; Denali Therapeutics Inc., South San Francisco, CA, USA., Robles-Colmenares Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Roche E; Denali Therapeutics Inc., South San Francisco, CA, USA., Sanders L; Denali Therapeutics Inc., South San Francisco, CA, USA., Stergioulis A; Denali Therapeutics Inc., South San Francisco, CA, USA., Tong R; Denali Therapeutics Inc., South San Francisco, CA, USA., Tran H; Denali Therapeutics Inc., South San Francisco, CA, USA., Zuchero Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Estrada AA; Denali Therapeutics Inc., South San Francisco, CA, USA., Gadkar K; Denali Therapeutics Inc., South San Francisco, CA, USA., Koth CMM; Denali Therapeutics Inc., South San Francisco, CA, USA., Sanchez PE; Denali Therapeutics Inc., South San Francisco, CA, USA., Thorne RG; Denali Therapeutics Inc., South San Francisco, CA, USA., Watts RJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Sandmann T; Denali Therapeutics Inc., South San Francisco, CA, USA., Kane LA; Denali Therapeutics Inc., South San Francisco, CA, USA., Rigo F; Ionis Pharmaceuticals, Carlsbad, CA, USA., Dennis MS; Denali Therapeutics Inc., South San Francisco, CA, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA, USA., DeVos SL; Denali Therapeutics Inc., South San Francisco, CA, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Aug 14; Vol. 16 (760), pp. eadi2245. Date of Electronic Publication: 2024 Aug 14.
Autor:
Craig RA 2nd; Denali Therapeutics Inc., South San Francisco, California 94080, United States., De Vicente J; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Estrada AA; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Feng JA; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Lexa KW; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Canet MJ; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Dowdle WE; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Erickson RI; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Flores BN; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Haddick PCG; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Kane LA; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Lewcock JW; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Moerke NJ; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Poda SB; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Sweeney Z; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Takahashi RH; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Tong V; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Wang J; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Yulyaningsih E; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Solanoy H; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Sanchez PE; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Tang L; Department of Chemistry, WuXi AppTec Co., Ltd., Tianjin 300457, China., Xu M; Department of Chemistry, WuXi AppTec Co., Ltd., Tianjin 300457, China., Zhang R; Department of Chemistry, WuXi AppTec Co., Ltd., Tianjin 300457, China., Osipov M; Denali Therapeutics Inc., South San Francisco, California 94080, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Apr 11; Vol. 67 (7), pp. 5758-5782. Date of Electronic Publication: 2024 Mar 21.
Autor:
Logan T, Simon MJ, Rana A, Cherf GM, Srivastava A, Davis SS, Yoon Low RL, Chiu CL, Fang M, Huang F, Bhalla A, Llapashtica C, Prorok R, Pizzo ME, Calvert MEK, Sun EW, Hsiao-Nakamoto J, Rajendra Y, Lexa KW, Srivastava DB, van Lengerich B, Wang J, Robles-Colmenares Y, Kim DJ, Duque J, Lenser M, Earr TK, Nguyen H, Chau R, Tsogtbaatar B, Ravi R, Skuja LL, Solanoy H, Rosen HJ, Boeve BF, Boxer AL, Heuer HW, Dennis MS, Kariolis MS, Monroe KM, Przybyla L, Sanchez PE, Meisner R, Diaz D, Henne KR, Watts RJ, Henry AG, Gunasekaran K, Astarita G, Suh JH, Lewcock JW, DeVos SL, Di Paolo G
Publikováno v:
Cell [Cell] 2024 Mar 14; Vol. 187 (6), pp. 1565-1566.
Autor:
TMT, JIO, Hernandez-Simón, Eustaqui, Rodellar-Oncins, MaTeresa, Arteaga-Salinas, Maite, IOG, HernÁndez-Huet, Enric, RosÁs-Redondo, Mireia, Pérez-López, Ana Maria, Echegaray-Carranza, Carolina, Montal-Codina, Jaume, Argila-Vicente, Montserrat, Sobrequés-Soriano, Jordi, León-Pérez, Ariel, Perramon-Rovira, Pilar, Prat-Benítez, Mireia, Aguyé-Batista, Amada, Bautista-Puente, Araceli, SÁnchez-Pe´rez, Ricardo, Leiva-Morote, Francisco, Solsona-TomÁs, Gisela, Oliveras-Cuquet, Josep, Arroyo-Rodríguez, Carlota, Sola-Ortigosa, Joaquin, Muñoz-Santos, Carlos, Otzet-Gramunt, Isabel, Masat-Ticó, Teresa, Isidro-Ortega, Joan, Guilabert, Antonio
Publikováno v:
In Journal of Investigative Dermatology July 2021 141(7):1837-1839
Autor:
Rodriguez LA; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Thomas TW; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.; Department of Epidemiology and Population Health, Stanford University School of Medicine, Palo Alto, CA, USA., Finertie H; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Wiley D; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Dyer WT; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Sanchez PE; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Yassin M; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Banerjee S; Kaiser Permanente, Oakland, CA, USA., Adams A; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Schmittdiel JA; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Publikováno v:
The Permanente journal [Perm J] 2023 Mar 15; Vol. 27 (1), pp. 56-71. Date of Electronic Publication: 2023 Mar 13.
Autor:
van Lengerich B; Denali Therapeutics, Inc., South San Francisco, CA, USA., Zhan L; Denali Therapeutics, Inc., South San Francisco, CA, USA., Xia D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Chan D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Joy D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Park JI; Denali Therapeutics, Inc., South San Francisco, CA, USA., Tatarakis D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Calvert M; Denali Therapeutics, Inc., South San Francisco, CA, USA., Hummel S; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Lianoglou S; Denali Therapeutics, Inc., South San Francisco, CA, USA., Pizzo ME; Denali Therapeutics, Inc., South San Francisco, CA, USA., Prorok R; Denali Therapeutics, Inc., South San Francisco, CA, USA., Thomsen E; Denali Therapeutics, Inc., South San Francisco, CA, USA., Bartos LM; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Beumers P; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Capell A; Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, Ludwig Maximilians University, Munich, Germany., Davis SS; Denali Therapeutics, Inc., South San Francisco, CA, USA., de Weerd L; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Dugas JC; Denali Therapeutics, Inc., South San Francisco, CA, USA., Duque J; Denali Therapeutics, Inc., South San Francisco, CA, USA., Earr T; Denali Therapeutics, Inc., South San Francisco, CA, USA., Gadkar K; Denali Therapeutics, Inc., South San Francisco, CA, USA., Giese T; Denali Therapeutics, Inc., South San Francisco, CA, USA., Gill A; Denali Therapeutics, Inc., South San Francisco, CA, USA., Gnörich J; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Ha C; Denali Therapeutics, Inc., South San Francisco, CA, USA., Kannuswamy M; Denali Therapeutics, Inc., South San Francisco, CA, USA., Kim DJ; Denali Therapeutics, Inc., South San Francisco, CA, USA., Kunte ST; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Kunze LH; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Lac D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Lechtenberg K; Denali Therapeutics, Inc., South San Francisco, CA, USA., Leung AW; Denali Therapeutics, Inc., South San Francisco, CA, USA., Liang CC; Denali Therapeutics, Inc., South San Francisco, CA, USA., Lopez I; Denali Therapeutics, Inc., South San Francisco, CA, USA., McQuade P; Takeda Pharmaceutical Company, Cambridge, MA, USA., Modi A; Denali Therapeutics, Inc., South San Francisco, CA, USA., Torres VO; Denali Therapeutics, Inc., South San Francisco, CA, USA., Nguyen HN; Denali Therapeutics, Inc., South San Francisco, CA, USA., Pesämaa I; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Graduate School of Systemic Neurosciences, Ludwig Maximilians University Munich, Planegg-Martinsried, Germany., Propson N; Denali Therapeutics, Inc., South San Francisco, CA, USA., Reich M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Graduate School of Systemic Neurosciences, Ludwig Maximilians University Munich, Planegg-Martinsried, Germany., Robles-Colmenares Y; Denali Therapeutics, Inc., South San Francisco, CA, USA., Schlepckow K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Slemann L; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Solanoy H; Denali Therapeutics, Inc., South San Francisco, CA, USA., Suh JH; Denali Therapeutics, Inc., South San Francisco, CA, USA., Thorne RG; Denali Therapeutics, Inc., South San Francisco, CA, USA., Vieira C; Denali Therapeutics, Inc., South San Francisco, CA, USA., Wind-Mark K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Xiong K; Denali Therapeutics, Inc., South San Francisco, CA, USA., Zuchero YJY; Denali Therapeutics, Inc., South San Francisco, CA, USA., Diaz D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Dennis MS; Denali Therapeutics, Inc., South San Francisco, CA, USA., Huang F; Denali Therapeutics, Inc., South San Francisco, CA, USA., Scearce-Levie K; Denali Therapeutics, Inc., South San Francisco, CA, USA., Watts RJ; Denali Therapeutics, Inc., South San Francisco, CA, USA., Haass C; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, Ludwig Maximilians University, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Lewcock JW; Denali Therapeutics, Inc., South San Francisco, CA, USA., Di Paolo G; Denali Therapeutics, Inc., South San Francisco, CA, USA., Brendel M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Sanchez PE; Denali Therapeutics, Inc., South San Francisco, CA, USA. sanchez@dnli.com., Monroe KM; Denali Therapeutics, Inc., South San Francisco, CA, USA. monroe@dnli.com.
Publikováno v:
Nature neuroscience [Nat Neurosci] 2023 Mar; Vol. 26 (3), pp. 416-429. Date of Electronic Publication: 2023 Jan 12.
Autor:
Xia D; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lianoglou S; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Sandmann T; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Calvert M; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Suh JH; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Thomsen E; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Dugas J; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., DeVos SL; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lin CC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Davis S; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Ha C; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Nguyen H; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Chau R; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Yulyaningsih E; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lopez I; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Masoud ST; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Liang CC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lin K; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Astarita G; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Khoury N; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Zuchero JY; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.; Department of Pharmaceutics, University of Minnesota, 9-177 Weaver-Densford Hall, 308 Harvard St. SE, Minneapolis, MN, 55455, USA., Shen K; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Miller S; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Palop JJ; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Garceau D; The Jackson Lab, Bar Harbor, Maine, USA., Sasner M; The Jackson Lab, Bar Harbor, Maine, USA., Whitesell JD; Allen Institute for Brain Science, Seattle, Washington, USA., Harris JA; Allen Institute for Brain Science, Seattle, Washington, USA., Hummel S; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Gnörich J; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Wind K; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Kunze L; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Zatcepin A; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Brendel M; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Willem M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Haass C; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig- Maximilians-Universität, München, 81377, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377, Munich, Germany., Barnett D; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA., Zimmer TS; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA., Orr AG; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA., Scearce-Levie K; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Di Paolo G; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Sanchez PE; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA. sanchez@dnli.com.
Publikováno v:
Molecular neurodegeneration [Mol Neurodegener] 2022 Jun 11; Vol. 17 (1), pp. 41. Date of Electronic Publication: 2022 Jun 11.
Autor:
Arguello A; Denali Therapeutics Inc., South San Francisco, CA., Mahon CS; Denali Therapeutics Inc., South San Francisco, CA., Calvert MEK; Denali Therapeutics Inc., South San Francisco, CA., Chan D; Denali Therapeutics Inc., South San Francisco, CA., Dugas JC; Denali Therapeutics Inc., South San Francisco, CA., Pizzo ME; Denali Therapeutics Inc., South San Francisco, CA., Thomsen ER; Denali Therapeutics Inc., South San Francisco, CA., Chau R; Denali Therapeutics Inc., South San Francisco, CA., Damo LA; Denali Therapeutics Inc., South San Francisco, CA., Duque J; Denali Therapeutics Inc., South San Francisco, CA., Fang M; Denali Therapeutics Inc., South San Francisco, CA., Giese T; Denali Therapeutics Inc., South San Francisco, CA., Kim DJ; Denali Therapeutics Inc., South San Francisco, CA., Liang N; Denali Therapeutics Inc., South San Francisco, CA., Nguyen HN; Denali Therapeutics Inc., South San Francisco, CA., Solanoy H; Denali Therapeutics Inc., South San Francisco, CA., Tsogtbaatar B; Denali Therapeutics Inc., South San Francisco, CA., Ullman JC; Denali Therapeutics Inc., South San Francisco, CA., Wang J; Denali Therapeutics Inc., South San Francisco, CA., Dennis MS; Denali Therapeutics Inc., South San Francisco, CA., Diaz D; Denali Therapeutics Inc., South San Francisco, CA., Gunasekaran K; Denali Therapeutics Inc., South San Francisco, CA., Henne KR; Denali Therapeutics Inc., South San Francisco, CA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA., Sanchez PE; Denali Therapeutics Inc., South San Francisco, CA., Troyer MD; Denali Therapeutics Inc., South San Francisco, CA., Harris JM; Denali Therapeutics Inc., South San Francisco, CA., Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, CA., Shan L; Denali Therapeutics Inc., South San Francisco, CA., Watts RJ; Denali Therapeutics Inc., South San Francisco, CA., Thorne RG; Denali Therapeutics Inc., South San Francisco, CA.; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN., Henry AG; Denali Therapeutics Inc., South San Francisco, CA., Kariolis MS; Denali Therapeutics Inc., South San Francisco, CA.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2022 Mar 07; Vol. 219 (3). Date of Electronic Publication: 2022 Feb 28.
Autor:
Arguello A; Denali Therapeutics Inc., South San Francisco, California, USA., Meisner R; Denali Therapeutics Inc., South San Francisco, California, USA., Thomsen ER; Denali Therapeutics Inc., South San Francisco, California, USA., Nguyen HN; Denali Therapeutics Inc., South San Francisco, California, USA., Ravi R; Denali Therapeutics Inc., South San Francisco, California, USA., Simms J; Behavioral Core, Gladstone Institute of Neurological Disease, San Francisco, California, USA., Lo I; Behavioral Core, Gladstone Institute of Neurological Disease, San Francisco, California, USA., Speckart J; Behavioral Core, Gladstone Institute of Neurological Disease, San Francisco, California, USA., Holtzman J; Behavioral Core, Gladstone Institute of Neurological Disease, San Francisco, California, USA., Gill TM; Behavioral Core, Gladstone Institute of Neurological Disease, San Francisco, California, USA., Chan D; Denali Therapeutics Inc., South San Francisco, California, USA., Cheng Y; Denali Therapeutics Inc., South San Francisco, California, USA., Chiu CL; Denali Therapeutics Inc., South San Francisco, California, USA., Dugas JC; Denali Therapeutics Inc., South San Francisco, California, USA., Fang M; Denali Therapeutics Inc., South San Francisco, California, USA., Lopez IA; Denali Therapeutics Inc., South San Francisco, California, USA., Solanoy H; Denali Therapeutics Inc., South San Francisco, California, USA., Tsogtbaatar B; Denali Therapeutics Inc., South San Francisco, California, USA., Zhu Y; Denali Therapeutics Inc., South San Francisco, California, USA., Bhalla A; Denali Therapeutics Inc., South San Francisco, California, USA., Henne KR; Denali Therapeutics Inc., South San Francisco, California, USA., Henry AG; Denali Therapeutics Inc., South San Francisco, California, USA., Delucchi A; Denali Therapeutics Inc., South San Francisco, California, USA., Costanzo S; Denali Therapeutics Inc., South San Francisco, California, USA., Harris JM; Denali Therapeutics Inc., South San Francisco, California, USA., Diaz D; Denali Therapeutics Inc., South San Francisco, California, USA., Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, California, USA., Sanchez PE; Denali Therapeutics Inc., South San Francisco, California, USA.
Publikováno v:
JCI insight [JCI Insight] 2021 Oct 08; Vol. 6 (19). Date of Electronic Publication: 2021 Oct 08.